Search Results

There are 6100543 results for: content related to: DIETHYLSTILBESTROL IN CASTRATION-RESISTANT PROSTATE CANCER

  1. You have free access to this content
    New developments in castrate-resistant prostate cancer

    BJU International

    Volume 109, Issue s6, June 2012, Pages: 22–32, N. Shore, M. Mason and Th. M. de Reijke

    Version of Record online : 4 JUN 2012, DOI: 10.1111/j.1464-410X.2012.11217.x

  2. You have free access to this content
    Novel therapeutics for the management of castration-resistant prostate cancer (CRPC)

    BJU International

    Volume 109, Issue 7, April 2012, Pages: 968–985, Daniel J. Lee, Eugene K. Cha, Justin M. Dubin, Himisha Beltran, Thomas F. Chromecki, Harun Fajkovic, Douglas S. Scherr, Scott T. Tagawa and Shahrokh F. Shariat

    Version of Record online : 28 OCT 2011, DOI: 10.1111/j.1464-410X.2011.10643.x

  3. You have free access to this content
    Landmarks in non-hormonal pharmacological therapies for castration-resistant prostate cancer

    BJU International

    Volume 110, Issue s1, October 2012, Pages: 14–22, Noel W. Clarke

    Version of Record online : 10 OCT 2012, DOI: 10.1111/j.1464-410X.2012.11430.x

  4. You have free access to this content
    Urologists and oncologists: adapting to a new treatment paradigm in castration-resistant prostate cancer (CRPC)

    BJU International

    Volume 110, Issue 3, August 2012, Pages: 328–335, A. Oliver Sartor and John M. Fitzpatrick

    Version of Record online : 19 JUN 2012, DOI: 10.1111/j.1464-410X.2011.10818.x

  5. You have free access to this content
    Clinical development of novel therapeutics for castration-resistant prostate cancer

    CA: A Cancer Journal for Clinicians

    Volume 62, Issue 5, September/October 2012, Pages: 299–308, Matthew D. Galsky, Alexander C. Small, Che-kai Tsao and William K. Oh

    Version of Record online : 24 APR 2012, DOI: 10.3322/caac.21141

  6. You have free access to this content
    Optimizing the care of patients with advanced prostate cancer in the UK: current challenges and future opportunities

    BJU International

    Volume 110, Issue 5, September 2012, Pages: 658–667, Heather Payne, Amit Bahl, Malcolm Mason, Janis Troup and Johann De Bono

    Version of Record online : 19 MAR 2012, DOI: 10.1111/j.1464-410X.2011.10886.x

  7. You have free access to this content
    Targeting the androgen receptor signalling axis in castration-resistant prostate cancer (CRPC)

    BJU International

    Volume 110, Issue 11, December 2012, Pages: 1580–1588, Che-Kai Tsao, Matthew D. Galsky, Alexander C. Small, Tiffany Yee and William K. Oh

    Version of Record online : 18 SEP 2012, DOI: 10.1111/j.1464-410X.2012.11445.x

  8. You have free access to this content
    Castration-resistant prostate cancer: Many treatments, many options, many challenges ahead

    Cancer

    Volume 118, Issue 10, 15 May 2012, Pages: 2583–2593, Jorge A. Garcia and Brian I. Rini

    Version of Record online : 28 OCT 2011, DOI: 10.1002/cncr.26582

  9. You have free access to this content
    Diethylstilbestrol in castration-resistant prostate cancer

    BJU International

    Volume 110, Issue 11b, December 2012, Pages: E727–E735, Anna Wilkins, Mehdi Shahidi, Chris Parker, Ranga Gunapala, Karen Thomas, Robert Huddart, Alan Horwich and David Dearnaley

    Version of Record online : 30 OCT 2012, DOI: 10.1111/j.1464-410X.2012.11546.x

  10. You have free access to this content
    Phase II trial of RAD001 and bicalutamide for castration-resistant prostate cancer

    BJU International

    Volume 110, Issue 11, December 2012, Pages: 1729–1735, Mari Nakabayashi, Lilian Werner, Kevin D. Courtney, Geoffrey Buckle, William K. Oh, Glen J. Bubley, Julia H. Hayes, Douglas Weckstein, Aymen Elfiky, Danny M. Sims, Philip W. Kantoff and Mary-Ellen Taplin

    Version of Record online : 29 AUG 2012, DOI: 10.1111/j.1464-410X.2012.11456.x

  11. Interactions and relationships of PTEN, ERG, SPINK1 and AR in castration-resistant prostate cancer

    Histopathology

    Volume 60, Issue 4, March 2012, Pages: 645–652, Tarek A Bismar, Maisa Yoshimoto, Qiuli Duan, Shuhong Liu, Kanishka Sircar and Jeremy A Squire

    Version of Record online : 19 JAN 2012, DOI: 10.1111/j.1365-2559.2011.04116.x

  12. Variant allele of HSD3B1 increases progression to castration-resistant prostate cancer

    The Prostate

    Volume 75, Issue 7, May 15, 2015, Pages: 777–782, Gang Wu, Shengsong Huang, Kent L. Nastiuk, Jinliang Li, Jun Gu, Ming Wu, Qimin Zhang, Hanqing Lin and Denglong Wu

    Version of Record online : 1 MAR 2015, DOI: 10.1002/pros.22967

  13. You have full text access to this Open Access content
    Stanniocalcin 2 overexpression in castration-resistant prostate cancer and aggressive prostate cancer

    Cancer Science

    Volume 100, Issue 5, May 2009, Pages: 914–919, Kenji Tamura, Mutsuo Furihata, Su-Yong Chung, Motohide Uemura, Hiroki Yoshioka, Tatsuo Iiyama, Shingo Ashida, Yasutomo Nasu, Tomoaki Fujioka, Taro Shuin, Yusuke Nakamura and Hidewaki Nakagawa

    Version of Record online : 26 FEB 2009, DOI: 10.1111/j.1349-7006.2009.01117.x

  14. You have free access to this content
    Phase II study of docetaxel re-treatment in docetaxel-pretreated castration-resistant prostate cancer

    BJU International

    Volume 107, Issue 2, January 2011, Pages: 234–239, Giuseppe Di Lorenzo, Carlo Buonerba, Adriana Faiella, Pasquale Rescigno, Mimma Rizzo, Riccardo Autorino, Sisto Perdonà, Nando Riccardi, Sarah Scagliorini, Florinda Scognamiglio, Daniele Masala, Matteo Ferro, Giovannella Palmieri, Michele Aieta, Alfredo Marinelli, Vincenzo Altieri, Sabino De Placido and Giacomo Cartenì

    Version of Record online : 29 JUN 2010, DOI: 10.1111/j.1464-410X.2010.09498.x

  15. Somatic copy number alterations by whole-exome sequencing implicates YWHAZ and PTK2 in castration-resistant prostate cancer

    The Journal of Pathology

    Volume 231, Issue 4, December 2013, Pages: 505–516, Roopika Menon, Mario Deng, Kerstin Rüenauver, Angela Queisser, Martin Pfeifer, Anne Offermann, Diana Boehm, Wenzel Vogel, Veit Scheble, Falko Fend, Glen Kristiansen, Nicolas Wernert, Nicole Oberbeckmann, Saskia Biskup, Mark A Rubin, Zaki Shaikhibrahim and Sven Perner

    Version of Record online : 12 NOV 2013, DOI: 10.1002/path.4274

  16. You have free access to this content
    Prostate-specific antigen response to deferred combined androgen blockade therapy using bicalutamide predicts survival after subsequent oestrogen and docetaxel therapies in patients with castration-resistant prostate cancer

    BJU International

    Volume 110, Issue 8, October 2012, Pages: 1149–1155, Toshiki Kijima, Yasuhisa Fujii, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Fumitaka Koga, Hitoshi Masuda, Satoru Kawakami and Kazunori Kihara

    Version of Record online : 28 FEB 2012, DOI: 10.1111/j.1464-410X.2012.10959.x

  17. The presence and clinical implication of intraductal carcinoma of prostate in metastatic castration resistant prostate cancer

    The Prostate

    Volume 75, Issue 12, September 1, 2015, Pages: 1247–1254, Zhibin Chen, Ni Chen, Pengfei Shen, Jing Gong, Xiang Li, Tao Zhao, Banghua Liao, Liangren Liu, Zhenhua Liu, Xingming Zhang, Jiyan Liu, Zhufeng Peng, Xueqin Chen, Miao Xu, Haojun Gui, Peng Zhang, Qiang Wei, Qiao Zhou and Hao Zeng

    Version of Record online : 27 APR 2015, DOI: 10.1002/pros.23005

  18. Midkine is associated with neuroendocrine differentiation in castration-resistant prostate cancer

    The Prostate

    Volume 73, Issue 6, May 2013, Pages: 657–667, Anna Nordin, Wanzhong Wang, Karin Welén and Jan-Erik Damber

    Version of Record online : 5 NOV 2012, DOI: 10.1002/pros.22607

  19. The altered expression of MiR-221/-222 and MiR-23b/-27b is associated with the development of human castration resistant prostate cancer

    The Prostate

    Volume 72, Issue 10, 1 July 2012, Pages: 1093–1103, Tong Sun, Ming Yang, Shaoyong Chen, Steven Balk, Mark Pomerantz, Chen-Lin Hsieh, Myles Brown, Gwo-Shu Mary Lee and Philip W. Kantoff

    Version of Record online : 29 NOV 2011, DOI: 10.1002/pros.22456

  20. You have free access to this content
    Phase 3, randomized, placebo-controlled study of zibotentan (ZD4054) in patients with castration-resistant prostate cancer metastatic to bone

    Cancer

    Volume 118, Issue 22, 15 November 2012, Pages: 5709–5718, Joel B. Nelson, Karim Fizazi, Kurt Miller, Celestia Higano, Judd W. Moul, Hideyuki Akaza, Thomas Morris, Stuart McIntosh, Kristine Pemberton and Martin Gleave

    Version of Record online : 11 JUL 2012, DOI: 10.1002/cncr.27674